Sign in
4/A

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001465826-12-000011

Options or other derivatives

  • Director acquired 187.5 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

NARINE JEENARINE · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Underlying Owned after D/I
2012-06-29 Grant or award : show line 1 in the form Series E Convertible Preferred Stock +187.5 $1,000.00 $187,500 $0.02 7,684,427 1,937.5 I
Loading xslF345X03/primary_doc.xml…